erlotinib hydrochloride has been researched along with artesunic acid in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (artesunic acid) | Trials (artesunic acid) | Recent Studies (post-2010) (artesunic acid) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 2,089 | 443 | 1,182 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Efferth, T; Gebhart, E; Halatsch, ME; Ramirez, T | 1 |
| Efferth, T | 1 |
1 review(s) available for erlotinib hydrochloride and artesunic acid
| Article | Year |
|---|---|
Cancer combination therapy of the sesquiterpenoid artesunate and the selective EGFR-tyrosine kinase inhibitor erlotinib.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; ErbB Receptors; Erlotinib Hydrochloride; Humans; Molecular Targeted Therapy; Protein Kinase Inhibitors | 2017 |
1 other study(ies) available for erlotinib hydrochloride and artesunic acid
| Article | Year |
|---|---|
Combination treatment of glioblastoma multiforme cell lines with the anti-malarial artesunate and the epidermal growth factor receptor tyrosine kinase inhibitor OSI-774.
Topics: Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Cell Division; Cell Line; Cluster Analysis; Drug Screening Assays, Antitumor; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Glioblastoma; Humans; Nucleic Acid Hybridization; Quinazolines; Sesquiterpenes; Tumor Cells, Cultured | 2004 |